BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sudano I, Spieker LE, Noll G, Corti R, Weber R, Lüscher TF. Cardiovascular disease in HIV infection. Am Heart J 2006;151:1147-55. [PMID: 16781213 DOI: 10.1016/j.ahj.2005.07.030] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Sánchez Marteles M, Sierra Bergua B, Letona Carbajo S, Sanjoaquin Conde I. Miocarditis y meningoencefalitis como forma de presentación de una primoinfección por el virus de la inmunodeficiencia humana-1. Medicina Clínica 2008;130:598-9. [DOI: 10.1157/13119965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Low H, Cheng L, Di Yacovo MS, Churchill MJ, Meikle P, Bukrinsky M, Hill AF, Sviridov D. Lipid metabolism in patients infected with Nef-deficient HIV-1 strain. Atherosclerosis 2016;244:22-8. [PMID: 26581048 DOI: 10.1016/j.atherosclerosis.2015.10.103] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
3 Reinsch N, Buhr C, Krings P, Kaelsch H, Neuhaus K, Wieneke H, Erbel R, Neumann T; the German Heart Failure Network. Prevalence and Risk Factors of Prolonged QTc Interval in HIV-Infected Patients: Results of the HIV-HEART Study. HIV Clinical Trials 2015;10:261-8. [DOI: 10.1310/hct1004-261] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
4 Fukui Y, Aoki K, Ishii Y, Tateda K. The palatine tonsil bacteriome, but not the mycobiome, is altered in HIV infection. BMC Microbiol 2018;18:127. [PMID: 30290791 DOI: 10.1186/s12866-018-1274-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
5 Grant M, Samuel R, Bettiker RL, Suh B. Antiretroviral therapy 2010 update: Current practices and controversies. Arch Pharm Res 2011;34:1045-53. [DOI: 10.1007/s12272-011-0701-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
6 de las Fuentes L, de Simone G, Arnett DK, Dávila-Román VG. Molecular determinants of the cardiometabolic phenotype. Endocr Metab Immune Disord Drug Targets 2010;10:109-23. [PMID: 20384572 DOI: 10.2174/187153010791213119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
7 Crothers K, Goulet JL, Rodriguez-Barradas MC, Gibert CL, Oursler KA, Goetz MB, Crystal S, Leaf DA, Butt AA, Braithwaite RS, Peck R, Justice AC. Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans. AIDS Educ Prev 2009;21:40-53. [PMID: 19537953 DOI: 10.1521/aeap.2009.21.3_supp.40] [Cited by in Crossref: 81] [Cited by in F6Publishing: 83] [Article Influence: 6.2] [Reference Citation Analysis]
8 Tadewos A, Addis Z, Ambachew H, Banerjee S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther 2012;9:31. [PMID: 23095661 DOI: 10.1186/1742-6405-9-31] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
9 Fourie CM, Van Rooyen JM, Kruger A, Schutte AE. Lipid abnormalities in a never-treated HIV-1 subtype C-infected African population. Lipids 2010;45:73-80. [PMID: 19916038 DOI: 10.1007/s11745-009-3369-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
10 Guo W, Wong S, Pudney J, Jasuja R, Hua N, Jiang L, Miller A, Hruz PW, Hamilton JA, Bhasin S. Acipimox, an inhibitor of lipolysis, attenuates atherogenesis in LDLR-null mice treated with HIV protease inhibitor ritonavir. Arterioscler Thromb Vasc Biol 2009;29:2028-32. [PMID: 19762785 DOI: 10.1161/ATVBAHA.109.191304] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
11 Mavroudis CA, Majumder B, Loizides S, Christophides T, Johnson M, Rakhit RD. Coronary artery disease and HIV; getting to the HAART of the matter. International Journal of Cardiology 2013;167:1147-53. [DOI: 10.1016/j.ijcard.2012.09.043] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
12 Mcginnis KA, Skanderson M, Justice AC, Tindle HA, Akgün KM, Wrona A, Freiberg MS, Goetz MB, Rodriguez-barradas MC, Brown ST, Crothers KA. Using the biomarker cotinine and survey self-report to validate smoking data from United States Veterans Health Administration electronic health records. JAMIA Open 2022;5:ooac040. [DOI: 10.1093/jamiaopen/ooac040] [Reference Citation Analysis]
13 Egan G, Hughes CA, Ackman ML. Drug Interactions Between Antiplatelet or Novel Oral Anticoagulant Medications and Antiretroviral Medications. Ann Pharmacother 2014;48:734-40. [DOI: 10.1177/1060028014523115] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
14 Castillo JG, Adams DH, Rahmanian PB, Filsoufi F. Cirugía cardiovascular en pacientes con VIH: epidemiología, indicaciones actuales y resultados a largo plazo. Revista Española de Cardiología 2008;61:480-6. [DOI: 10.1157/13119991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, Hare JM, Heidecker B, Heymans S, Hübner N, Kelle S, Klingel K, Maatz H, Parwani AS, Spillmann F, Starling RC, Tsutsui H, Seferovic P, Van Linthout S. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol 2021;18:169-93. [PMID: 33046850 DOI: 10.1038/s41569-020-00435-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 28.5] [Reference Citation Analysis]
16 Petrovic K, Blank TO, Walla P. The Andersen–Newman Behavioral Model of Health Service Use as a conceptual basis for understanding patient behavior within the patient–physician dyad: The influence of trust on adherence to statins in older people living with HIV and cardiovascular disease. Cogent Psychology 2015;2:1038894. [DOI: 10.1080/23311908.2015.1038894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Monsuez J, Charniot J, Escaut L, Teicher E, Wyplosz B, Couzigou C, Vignat N, Vittecoq D. HIV-associated vascular diseases: Structural and functional changes, clinical implications. International Journal of Cardiology 2009;133:293-306. [DOI: 10.1016/j.ijcard.2008.11.113] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
18 Fourie CM, Schutte AE, Smith W, Kruger A, van Rooyen JM. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans. Atherosclerosis 2015;240:154-60. [PMID: 25795556 DOI: 10.1016/j.atherosclerosis.2015.03.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
19 Lewinter MM, Tischler MD. Pericardial Diseases. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier; 2012. pp. 1651-71. [DOI: 10.1016/b978-1-4377-0398-6.00075-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Farrugia PM, Lucariello R, Coppola JT. Human immunodeficiency virus and atherosclerosis. Cardiol Rev 2009;17:211-5. [PMID: 19690471 DOI: 10.1097/CRD.0b013e3181b151a3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
21 Mohamed Buhary T, Gayed SL, Hafeez I. Pericardial effusion with Mycobacterium avium complex in HIV-infected patients. BMJ Case Rep 2016;2016:bcr2016215686. [PMID: 27389727 DOI: 10.1136/bcr-2016-215686] [Reference Citation Analysis]
22 Raj SR, Stein CM, Saavedra PJ, Roden DM. Cardiovascular effects of noncardiovascular drugs. Circulation 2009;120:1123-32. [PMID: 19770411 DOI: 10.1161/CIRCULATIONAHA.107.728576] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
23 Lorenc A, Ananthavarathan P, Lorigan J, Jowata M, Brook G, Banarsee R. The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough. London J Prim Care (Abingdon) 2014;6:84-90. [PMID: 25949722 DOI: 10.1080/17571472.2014.11493422] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
24 Calmy A, Gayet-Ageron A, Montecucco F, Nguyen A, Mach F, Burger F, Ubolyam S, Carr A, Ruxungtham K, Hirschel B, Ananworanich J; STACCATO Study Group. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS 2009;23:929-39. [PMID: 19425222 DOI: 10.1097/qad.0b013e32832995fa] [Cited by in Crossref: 108] [Cited by in F6Publishing: 66] [Article Influence: 8.3] [Reference Citation Analysis]
25 Gopal M, Bhaskaran A, Khalife WI, Barbagelata A. Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem. Curr Cardiol Rev 2009;5:149-54. [PMID: 20436855 DOI: 10.2174/157340309788166705] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
26 Boccara F. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors. AIDS 2008;22 Suppl 3:S19-26. [PMID: 18845918 DOI: 10.1097/01.aids.0000327512.76126.6e] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.3] [Reference Citation Analysis]
27 Hirigo AT, Tesfaye DY. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia. BMC Res Notes. 2016;9:145. [PMID: 26945987 DOI: 10.1186/s13104-016-1953-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
28 Ferraioli G, Tinelli C, Maggi P, Gervasoni C, Grima P, Viskovic K, Carerj S, Filice G, Filice C; the Arterial Stiffness Evaluation in HIV-Infected Subjects Study Group. Arterial Stiffness Evaluation in HIV-Positive Patients: A Multicenter Matched Control Study. American Journal of Roentgenology 2011;197:1258-62. [DOI: 10.2214/ajr.11.6712] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
29 Dau B, Holodniy M. The Relationship Between HIV Infection and Cardiovascular Disease. Curr Cardiol Rev 2008;4:203-18. [PMID: 19936197 DOI: 10.2174/157340308785160589] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
30 Maranhão RC, Freitas FR. HDL Metabolism and Atheroprotection. Elsevier; 2014. pp. 1-41. [DOI: 10.1016/b978-0-12-800141-7.00001-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 5] [Article Influence: 3.4] [Reference Citation Analysis]
31 Charbit B, Rosier A, Bollens D, Boccara F, Boelle PY, Koubaa A, Girard PM, Funck-Brentano C. Relationship between HIV protease inhibitors and QTc interval duration in HIV-infected patients: a cross-sectional study. Br J Clin Pharmacol 2009;67:76-82. [PMID: 19076152 DOI: 10.1111/j.1365-2125.2008.03332.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
32 Alharethi R. Cardiovascular involvements in HIV-infected patients. Expert Rev Cardiovasc Ther 2013;11:1227-35. [PMID: 23972010 DOI: 10.1586/14779072.2013.832481] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Rana MA, Beedupalli J, Akkus NI. Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV. Case Rep Vasc Med 2015;2015:157623. [PMID: 25685591 DOI: 10.1155/2015/157623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Botha S, Fourie CM, van Rooyen JM, Kruger A, Schutte AE. Cardiometabolic Changes in Treated Versus Never Treated HIV-Infected Black South Africans: The PURE Study. Heart, Lung and Circulation 2014;23:119-26. [DOI: 10.1016/j.hlc.2013.07.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
35 Cui HL, Ditiatkovski M, Kesani R, Bobryshev YV, Liu Y, Geyer M, Mukhamedova N, Bukrinsky M, Sviridov D. HIV protein Nef causes dyslipidemia and formation of foam cells in mouse models of atherosclerosis. FASEB J 2014;28:2828-39. [PMID: 24642731 DOI: 10.1096/fj.13-246876] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
36 de Almeida ER, Reiche EM, Kallaur AP, Flauzino T, Watanabe MA. The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. Biomed Res Int. 2013;2013:836790. [PMID: 24319689 DOI: 10.1155/2013/836790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
37 Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P. Viral causes of human myocarditis. Arch Cardiovasc Dis 2009;102:559-68. [PMID: 19664576 DOI: 10.1016/j.acvd.2009.04.010] [Cited by in Crossref: 121] [Cited by in F6Publishing: 104] [Article Influence: 9.3] [Reference Citation Analysis]
38 Vlachopoulos C, Sambatakou H, Tsiachris D, Mariolis I, Aznaouridis K, Ioakeimidis N, Archimandritis AJ, Stefanadis C. Impact of human immunodeficiency virus infection on arterial stiffness and wave reflections in the early disease stages. ARTRES 2009;3:104. [DOI: 10.1016/j.artres.2009.08.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
39 Pere D, Ignacio SL, Ramón T, Fernando L, Alberto T, Pompeyo V, Juan G, M José G, Paloma G, Antonio V, Jaime C, Esteban R, Bernardino R, M Luisa GA, Trinitario S, Ferran T, Juan Ramón L, Myriam G. Dyslipidemia and cardiovascular disease risk factor management in HIV-1-infected subjects treated with HAART in the Spanish VACH cohort. Open AIDS J 2008;2:26-38. [PMID: 18923695 DOI: 10.2174/1874613600802010026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
40 Loelius SG, Lannan KL, Blumberg N, Phipps RP, Spinelli SL. The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro. Thromb Res 2018;169:96-104. [PMID: 30031293 DOI: 10.1016/j.thromres.2018.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
41 Nsagha DS, Weledji EP, Assob NJ, Njunda LA, Tanue EA, Kibu OD, Ayima CW, Ngowe MN. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon. BMC Cardiovasc Disord 2015;15:95. [PMID: 26315756 DOI: 10.1186/s12872-015-0090-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
42 Ogeng'o JA, Gatonga PM, Olabu BO, Nyamweya DK, Ong'era D. Pattern of congestive heart failure in a Kenyan paediatric population. Cardiovasc J Afr 2013;24:117-20. [PMID: 24217041 DOI: 10.5830/CVJA-2013-015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
43 Bahrami H, Budoff M, Haberlen SA, Rezaeian P, Ketlogetswe K, Tracy R, Palella F, Witt MD, McConnell MV, Kingsley L, Post WS. Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study. J Am Heart Assoc 2016;5:e003371. [PMID: 27353609 DOI: 10.1161/JAHA.116.003371] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
44 Woldu M, Minzi O, Engidawork E. Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review. J Diabetes Metab Disord 2020;19:1671-83. [PMID: 33553042 DOI: 10.1007/s40200-020-00552-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
45 Mendes L, Silva D, Miranda C, Sá J, Duque L, Duarte N, Brito P, Bernardino L, Poças J. Impact of HIV infection on cardiac deformation. Revista Portuguesa de Cardiologia (English Edition) 2014;33:501-9. [DOI: 10.1016/j.repce.2013.12.006] [Reference Citation Analysis]
46 Sims DB, Uriel N, González-Costello J, Deng MC, Restaino SW, Farr MA, Takayama H, Mancini DM, Naka Y, Jorde UP. Human immunodeficiency virus infection and left ventricular assist devices: a case series. J Heart Lung Transplant. 2011;30:1060-1064. [PMID: 21515076 DOI: 10.1016/j.healun.2011.03.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
47 Kline ER, Sutliff RL. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med 2008;56:752-69. [PMID: 18525451 DOI: 10.1097/JIM.0b013e3181788d15] [Cited by in Crossref: 63] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
48 Crothers K, Goulet JL, Rodriguez-Barradas MC, Gibert CL, Butt AA, Braithwaite RS, Peck R, Justice AC. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 2007;22:749-54. [PMID: 17503106 DOI: 10.1007/s11606-007-0158-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
49 He T, Falwell E, Brocca-Cofano E, Pandrea I. Modeling aging in HIV infection in nonhuman primates to address an emerging challenge of the post-ART era. Curr Opin Virol 2017;25:66-75. [PMID: 28803049 DOI: 10.1016/j.coviro.2017.07.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Deidda M, Dessalvi CC, Campus S, Ortu F, Piano P, Bassareo PP, Mercuro G. Early Right Ventricular Dysfunction in Highly Selected (Totally Free from Cardiovascular Risk Factors and Other Comorbidities) Human Immunodeficiency Virus Patients: A Pilot Study with Advanced Echocardiography. J Cardiovasc Echogr 2018;28:228-32. [PMID: 30746326 DOI: 10.4103/jcecho.jcecho_43_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 Shahrir S, Crothers K, McGinnis KA, Chan KCG, Baeten JM, Wilson SM, Butt AA, Pisani MA, Baldassarri SR, Justice A, Williams EC. Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV. Prog Cardiovasc Dis 2020;63:118-24. [PMID: 31987807 DOI: 10.1016/j.pcad.2020.01.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
52 Lai H, Redheuil A, Tong W, Bluemke DA, Lima JA, Ren S, Lai S. HIV infection and abnormal regional ventricular function. Int J Cardiovasc Imaging 2009;25:809-17. [PMID: 19763877 DOI: 10.1007/s10554-009-9493-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
53 McGinnis KA, Brandt CA, Skanderson M, Justice AC, Shahrir S, Butt AA, Brown ST, Freiberg MS, Gibert CL, Goetz MB, Kim JW, Pisani MA, Rimland D, Rodriguez-Barradas MC, Sico JJ, Tindle HA, Crothers K. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source.Nicotine Tob Res. 2011;13:1233-1239. [PMID: 21911825 DOI: 10.1093/ntr/ntr206] [Cited by in Crossref: 131] [Cited by in F6Publishing: 140] [Article Influence: 11.9] [Reference Citation Analysis]
54 Thomas CM, Smart EJ. How HIV protease inhibitors promote atherosclerotic lesion formation. Curr Opin Lipidol 2007;18:561-5. [PMID: 17885428 DOI: 10.1097/MOL.0b013e3282ef604f] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
55 Hacker MA, Kaida A, Hogg RS, Bastos FI. The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006. Cad Saude Publica 2007;23 Suppl 3:S345-59. [PMID: 17992341 DOI: 10.1590/s0102-311x2007001500003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
56 Syed FF, Millar BC, Prendergast BD. Molecular Technology in Context: A Current Review of Diagnosis and Management of Infective Endocarditis. Progress in Cardiovascular Diseases 2007;50:181-97. [DOI: 10.1016/j.pcad.2007.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
57 Munteanu A, Zingg JM. Cellular, molecular and clinical aspects of vitamin E on atherosclerosis prevention. Mol Aspects Med 2007;28:538-90. [PMID: 17825403 DOI: 10.1016/j.mam.2007.07.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
58 Rose H, Low H, Dewar E, Bukrinsky M, Hoy J, Dart A, Sviridov D. The effect of HIV infection on atherosclerosis and lipoprotein metabolism: a one year prospective study. Atherosclerosis 2013;229:206-11. [PMID: 23642913 DOI: 10.1016/j.atherosclerosis.2013.04.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
59 Ho JN, Yoon HG, Park CS, Kim S, Jun W, Choue R, Lee J. Isothiocyanates ameliorate the symptom of heart dysfunction and mortality in a murine AIDS model by inhibiting apoptosis in the left ventricle. J Med Food 2012;15:781-7. [PMID: 22925072 DOI: 10.1089/jmf.2011.1906] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
60 Jiang J, Fu W, Wang X, Lin PH, Yao Q, Chen C. HIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cells. Cardiovasc Res. 2010;87:366-374. [PMID: 20083573 DOI: 10.1093/cvr/cvq013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
61 Lang S, Boccara F, Mary-krause M, Cohen A. Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries. Archives of Cardiovascular Diseases 2015;108:206-15. [DOI: 10.1016/j.acvd.2015.01.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
62 Lambert CT, Sandesara PB, Hirsh B, Shaw LJ, Lewis W, Quyyumi AA, Schinazi RF, Post WS, Sperling L. HIV, highly active antiretroviral therapy and the heart: a cellular to epidemiological review. HIV Med 2016;17:411-24. [PMID: 26611380 DOI: 10.1111/hiv.12346] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
63 Martín-Reyes R, Galeote G, Moreno R, Sánchez-Recalde A, López De Sá E, López-Sendón JL. [Percutaneous coronary intervention in HIV infected patients with human immunodeficiency virus admitted with acute coronary syndrome: case-control study]. Med Clin (Barc) 2010;135:691-4. [PMID: 20599234 DOI: 10.1016/j.medcli.2010.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
64 Mascitelli L, Goldstein MR. The role of iron in HIV infection and its related cardiovascular complications. J Cardiovasc Med (Hagerstown) 2014;15:883-4. [PMID: 25353975 DOI: 10.2459/JCM.0b013e328365aa65] [Reference Citation Analysis]
65 Ayers J, Mandell R, Sanghvi K, Aboujaoude R, Hsi DH. Acute coronary thrombosis and multiple coronary aneurysms in a 22-year-old man with the human immunodeficiency virus. Tex Heart Inst J 2014;41:208-11. [PMID: 24808786 DOI: 10.14503/THIJ-13-3160] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Lamers SL, Salemi M, Galligan DC, Morris A, Gray R, Fogel G, Zhao L, McGrath MS. Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol 2010;16:230-41. [PMID: 20367240 DOI: 10.3109/13550281003735709] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
67 Becker AC, Jacobson B, Singh S, Sliwa K, Stewart S, Libhaber E, Essop MR. The thrombotic profile of treatment-naive HIV-positive Black South Africans with acute coronary syndromes. Clin Appl Thromb Hemost 2011;17:264-72. [PMID: 20460356 DOI: 10.1177/1076029609358883] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
68 Zanone Poma B, Riva A, Nasi M, Cicconi P, Broggini V, Lepri AC, Mologni D, Mazzotta F, Monforte AD, Mussini C, Cossarizza A, Galli M; Icona Foundation Study Group. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy. AIDS 2008;22:1769-78. [PMID: 18753860 DOI: 10.1097/QAD.0b013e32830b3a96] [Cited by in Crossref: 42] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
69 Whitwam W, Rule S, Narayan SM. Noncontact mapping of small pulmonary artery potentials preceding ectopy from the right ventricular outflow tract. Heart Rhythm 2007;4:959-63. [DOI: 10.1016/j.hrthm.2007.01.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
70 Namai A, Sakurai M, Akiyama M. Cardiac surgery in three patients infected with the human immunodeficiency virus. Gen Thorac Cardiovasc Surg 2008;56:465-7. [PMID: 18791674 DOI: 10.1007/s11748-008-0276-1] [Reference Citation Analysis]
71 Kietsiriroje N, Leelawattana R. Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over study. BMC Res Notes 2015;8:294. [PMID: 26148680 DOI: 10.1186/s13104-015-1225-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
72 Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007;102:2536-40. [PMID: 17640321 DOI: 10.1111/j.1572-0241.2007.01428.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 5.4] [Reference Citation Analysis]
73 Carvalho AS, Osório Valente R, Almeida Morais L, Modas Daniel P, Sá Carvalho R, Ferreira L, Cruz Ferreira R. HIV and coronary disease - When secondary prevention is insufficient. Rev Port Cardiol 2017;36:569.e1-8. [PMID: 28697899 DOI: 10.1016/j.repc.2016.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
74 Ivanov AV, Valuev-Elliston VT, Ivanova ON, Kochetkov SN, Starodubova ES, Bartosch B, Isaguliants MG. Oxidative Stress during HIV Infection: Mechanisms and Consequences. Oxid Med Cell Longev 2016;2016:8910396. [PMID: 27829986 DOI: 10.1155/2016/8910396] [Cited by in Crossref: 130] [Cited by in F6Publishing: 133] [Article Influence: 21.7] [Reference Citation Analysis]
75 George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS 2010;24:387-94. [PMID: 20019575 DOI: 10.1097/QAD.0b013e3283359253] [Cited by in Crossref: 69] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
76 Zhao L, Galligan DC, Lamers SL, Yu S, Shagrun L, Salemi M, McGrath MS. High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS. Sci China C Life Sci 2009;52:651-6. [PMID: 19641870 DOI: 10.1007/s11427-009-0085-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
77 Kline ER, Kleinhenz DJ, Liang B, Dikalov S, Guidot DM, Hart CM, Jones DP, Sutliff RL. Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration. Am J Physiol Heart Circ Physiol 2008;294:H2792-804. [PMID: 18456725 DOI: 10.1152/ajpheart.91447.2007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
78 Lazar J, Holman S, Minkoff HL, Dehovitz JA, Sharma A. Interarm blood pressure differences in the women's interagency HIV study. AIDS Res Hum Retroviruses 2008;24:695-700. [PMID: 18507529 DOI: 10.1089/aid.2007.0237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
79 Faber J, Bech A, van Bentum P, Gisolf J, Hassing RJ, de Boer H. Long-Term Impact of Calcium and Vitamin D Supplementation on Bone Density in HIV+ Patients with Documented Deficiencies. AIDS Res Hum Retroviruses 2020;36:58-64. [PMID: 31523978 DOI: 10.1089/AID.2019.0109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
80 Coquet I, Pavie J, Palmer P, Barbier F, Legriel S, Mayaux J, Molina JM, Schlemmer B, Azoulay E. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 2010;14:R107. [PMID: 20534139 DOI: 10.1186/cc9056] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
81 Khunnawat C, Mukerji S, Havlichek D Jr, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am J Cardiol 2008;102:635-42. [PMID: 18721528 DOI: 10.1016/j.amjcard.2008.04.035] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
82 Chango Azanza DX, Fernández B, Vásquez Ortiz Z, Chapa M, Rosales Uvera S. Cardiac Multimodality Imaging Assessment of Dystrophic Myocardial Calcification in a Human Immunodeficiency Virus-Infected Patient With Dilated Cardiomyopathy. Cureus 2021;13:e18707. [PMID: 34786270 DOI: 10.7759/cureus.18707] [Reference Citation Analysis]
83 Resino S, Micheloud D, Lorente R, Bellon JM, Navarro ML, Munoz-Fernandez MA. Adipokine profiles and lipodystrophy in HIV-infected children during the first 4 years on highly active antiretroviral therapy. HIV Med 2011;12:54-60. [PMID: 20497248 DOI: 10.1111/j.1468-1293.2010.00837.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
84 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
85 Seoane E, Resino S, Micheloud D, Moreno A, de Quiros JC, Lorente R, Rubio R, Gonzalez J, Pulido F, Arribas JR, Moreno S, Muñoz-Fernández M. Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption. J Acquir Immune Defic Syndr 2008;48:455-9. [PMID: 18614926 DOI: 10.1097/QAI.0b013e31817bbc07] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
86 Mendes L, Silva D, Miranda C, Sá J, Duque L, Duarte N, Brito P, Bernardino L, Poças J. Impact of HIV infection on cardiac deformation. Rev Port Cardiol 2014;33:501-9. [PMID: 25242674 DOI: 10.1016/j.repc.2013.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
87 Amariles P, Giraldo N, Faus M. Interacciones medicamentosas en pacientes infectados con el VIH: aproximación para establecer y evaluar su relevancia clínica. Farmacia Hospitalaria 2007;31:283-302. [DOI: 10.1016/s1130-6343(07)75392-8] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
88 Soliman EZ, Juma H. Cardiac disease patterns in northern Malawi: epidemiologic transition perspective. J Epidemiol 2008;18:204-8. [PMID: 18753734 DOI: 10.2188/jea.je2008006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
89 Ware LJ, Jackson AGA, Wootton SA, Burdge GC, Morlese JF, Moyle GJ, Jackson AA, Gazzard BG. Antiretroviral therapy with or without protease inhibitors impairs postprandial TAG hydrolysis in HIV-infected men. Br J Nutr 2009;102:1038-46. [DOI: 10.1017/s0007114509338817] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
90 Fisher SD, Kanda BS, Miller TL, Lipshultz SE. Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients: . American Journal Cardiovascular Drugs 2011;11:383-94. [DOI: 10.2165/11594590-000000000-00000] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
91 Chastain DB, King TS, Stover KR. Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection. Open AIDS J 2016;10:113-26. [PMID: 27583063 DOI: 10.2174/1874613601610010113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
92 Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol 2019;12:232-46. [PMID: 30171206 DOI: 10.1038/s41385-018-0083-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
93 Kushner LE, Wendelboe AM, Lazzeroni LC, Chary A, Winters MA, Osinusi A, Kottilil S, Polis MA, Holodniy M. Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients. PLoS One 2013;8:e60387. [PMID: 23593207 DOI: 10.1371/journal.pone.0060387] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
94 Lu Z. Second generation HIV protease inhibitors against resistant virus. Expert Opin Drug Discov 2008;3:775-86. [PMID: 23496220 DOI: 10.1517/17460441.3.7.775] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
95 El Hattaoui M, Charei N, Boumzebra D, Aajly L, Fadouach S. [Prevalence of cardiomyopathy in HIV infection: prospective study on 158 HIV patients]. Med Mal Infect 2008;38:387-91. [PMID: 18583077 DOI: 10.1016/j.medmal.2008.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
96 van Wagenberg FS, Lehr EJ, Rehman A, Bonatti J. Is there a role for robotic totally endoscopic coronary artery bypass in HIV positive patients? Int J Med Robot. 2010;6:465-467. [PMID: 20886464 DOI: 10.1002/rcs.356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
97 Eugenin EA, Morgello S, Klotman ME, Mosoian A, Lento PA, Berman JW, Schecter AD. Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol. 2008;172:1100-1111. [PMID: 18310503 DOI: 10.2353/ajpath.2008.070457] [Cited by in Crossref: 78] [Cited by in F6Publishing: 77] [Article Influence: 5.6] [Reference Citation Analysis]
98 Zhu H, Yuan J, Wang Y, Gao F, Wang X, Wei C, Chen J, Fan X, Zhang M. Long-term use of first-line highly active antiretroviral therapy is not associated with carotid artery stiffness in human immunodeficiency virus-positive patients. The Brazilian Journal of Infectious Diseases 2014;18:496-500. [DOI: 10.1016/j.bjid.2014.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
99 Belay AS, Manaye GA, Kebede KM, Abateneh DD. Predictors of Current CD4+ T-Cell Count Among Women of Reproductive Age on Antiretroviral Therapy in Public Hospitals, Southwest Ethiopia. HIV AIDS (Auckl) 2021;13:667-79. [PMID: 34168505 DOI: 10.2147/HIV.S294367] [Reference Citation Analysis]
100 Lipshultz SE, Mas CM, Henkel JM, Franco VI, Fisher SD, Miller TL. HAART to heart: highly active antiretroviral therapy and the risk of cardiovascular disease in HIV-infected or exposed children and adults. Expert Review of Anti-infective Therapy 2014;10:661-74. [DOI: 10.1586/eri.12.53] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
101 Woldu M, Minzi O, Shibeshi W, Shewaamare A, Engidawork E. Biomarkers and Prevalence of Cardiometabolic Syndrome Among People Living With HIV/AIDS, Addis Ababa, Ethiopia: A Hospital-Based Study. Clin Med Insights Endocrinol Diabetes 2022;15:11795514221078029. [PMID: 35237088 DOI: 10.1177/11795514221078029] [Reference Citation Analysis]
102 Atta MG, Estrella MM, Fine DM, Zook K, Monroy Trujillo JM, Stein JH, Lucas GM. Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals. PLoS One 2016;11:e0155312. [PMID: 27176000 DOI: 10.1371/journal.pone.0155312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
103 Vlachopoulos C, Xaplanteris P, Sambatakou H, Mariolis E, Bratsas A, Christoforatou E, Miliou A, Aznaouridis K, Stefanadis C. Acute systemic inflammation induced by influenza A (H1N1) vaccination causes a deterioration in endothelial function in HIV-infected patients: H1N1 vaccine and endothelial function. HIV Medicine 2011;12:594-601. [DOI: 10.1111/j.1468-1293.2011.00935.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
104 Venkat A, Piontkowsky DM, Cooney RR, Srivastava AK, Suares GA, Heidelberger CP. Care of the HIV-Positive Patient in the Emergency Department in the Era of Highly Active Antiretroviral Therapy. Annals of Emergency Medicine 2008;52:274-85. [DOI: 10.1016/j.annemergmed.2008.01.324] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
105 Kumar V, Kaur J, Panghal A, Kaur S, Handa V. Caffeine: a boon or bane. NFS 2018;48:61-75. [DOI: 10.1108/nfs-05-2017-0100] [Cited by in Crossref: 11] [Article Influence: 2.8] [Reference Citation Analysis]
106 Desvarieux M, Boccara F, Meynard JL, Bastard JP, Mallat Z, Charbit B, Demmer RT, Haddour N, Fellahi S, Tedgui A, Cohen A, Capeau J, Boyd A, Girard PM. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy. AIDS 2013;27:2603-14. [PMID: 24100713 DOI: 10.1097/QAD.0b013e3283634819] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
107 Singh S, Vatsa D, Tomar S, Aneja GK, S Arya TV. Cardiac complications in people living with human immunodeficiency virus/acquired immunodeficiency syndrome and their association with CD4+ T-cell count - A cross sectional study. Indian J Sex Transm Dis AIDS 2018;39:23-7. [PMID: 30187022 DOI: 10.4103/ijstd.IJSTD_18_16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Paraskevas KI, Katsiki N, Tzovaras AA, Koupidis SA, Mikhailidis DP. Peripheral arterial disease and HIV-positive patients. Angiology 2011;62:7-9. [PMID: 21134992 DOI: 10.1177/0003319710386473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
109 Shahrir S, Tindle HA, McGinnis KA, Fiellin DA, Goulet J, Akgün KM, Gibert CL, Rodriguez-Barradas MC, Crothers K. Contemplation of smoking cessation and quit attempts in human immunodeficiency virus-infected and uninfected veterans. Subst Abus 2016;37:315-22. [PMID: 26167725 DOI: 10.1080/08897077.2015.1062458] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
110 Vacher A, Chabrot P, Cassagnes L, Lesens O, Buc E, Pezet D, Laurichesse H, Boyer L. [Role of endovascular treatment of symptomatic splanchnic artery stenoses in HIV patients: report of three cases]. J Radiol 2009;90:221-4. [PMID: 19308007 DOI: 10.1016/s0221-0363(09)72473-4] [Reference Citation Analysis]
111 Huang JS, Becerra K, Fernandez S, Lee D, Mathews WC. The impact of HIV-associated lipodystrophy on healthcare utilization and costs. AIDS Res Ther 2008;5:14. [PMID: 18593479 DOI: 10.1186/1742-6405-5-14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]